INSULET CORPORATION Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-09-21: Form 8-K; Exhibit 10.1; Description Ninth Amendment to Credit Agreement, dated September 21, 2026, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto..
- 2026-09-16: Form 8-K; Exhibit 10.1; Description Insulet Nonqualified Deferred Compensation Plan.
- 2026-05-06: Form 10-Q; Exhibit 10.2; Description Offer Letter between Michael Panos and Insulet Corporation, dated March 9, 2026..
- 2026-05-06: Form 10-Q; Exhibit 10.1; Description Separation Agreement between Insulet Corporation and Ana Chadwick, dated February 10, 2026..
| Filed | Form | Exhibit | Description |
|---|
| 2026-09-21 | 8-K | 10.1 | Ninth Amendment to Credit Agreement, dated September 21, 2026, among Insulet Corporation, Insulet MA Securities Corporation, Morgan Stanley Senior Funding, Inc., as administrative agent, and the other lenders party thereto. |
|---|
| 2026-09-16 | 8-K | 10.1 | Insulet Nonqualified Deferred Compensation Plan |
|---|
| 2026-05-06 | 10-Q | 10.2 | Offer Letter between Michael Panos and Insulet Corporation, dated March 9, 2026. |
|---|
| 2026-05-06 | 10-Q | 10.1 | Separation Agreement between Insulet Corporation and Ana Chadwick, dated February 10, 2026. |
|---|
| 2026-02-18 | 10-K | 10.82 | Separation Agreement between Insulet Corporation and Daniel Manea, dated August 6, 2025 |
|---|
| 2026-02-18 | 10-K | 10.73 | Third Amendment to Master Equipment and Services Agreement originally dated August 31, 2016 between Insulet Corporation and ATS Automation Tooling Systems Inc., dated August 31, 2024 |
|---|
| 2026-02-18 | 10-K | 10.65 | Amendment No. 8, dated as of December 15, 2025, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021 |
|---|
| 2026-02-18 | 10-K | 10.64 | Amendment No. 7, dated as of October 28, 2025, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021 |
|---|
| 2026-02-18 | 10-K | 10.63 | Amendment No. 6, dated as of June 12, 2025, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021 |
|---|
| 2026-02-18 | 10-K | 10.62 | Amendment No. 5, dated as of December 19, 2024, to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care Inc. dated as of September 13, 2021 |
|---|
| 2026-02-18 | 10-K | 10.55 | Amendment No. 1. dated as of January 5, 2026 to the Commercialization Agreement by and between Insulet Corporation and DexCom, Inc, dated November 21, 2019 |
|---|
| 2026-02-18 | 10-K | 10.51 | Amended and Restated Materials Supplier Agreement between Insulet Corporation and Sanmina Corporation, effective November 14, 2025 |
|---|
| 2026-02-18 | 10-K | 10.25 | Form of Insulet Corporation 2025 Stock Option and Incentive Plan Performance Stock Unit Agreement |
|---|
| 2026-02-18 | 10-K | 10.24 | Form of Insulet Corporation 2025 Stock Option and Incentive Plan Restricted Stock Unit Agreement |
|---|
| 2026-02-18 | 10-K | 10.23 | Form of Insulet Corporation 2025 Stock Option and Incentive Plan Non-Qualified Stock Option Agreement |
|---|
| 2026-02-03 | 8-K | 10.1 | Addendum, effective January 1, 2026, to the Purchase Agreement by and between Insulet Corporation and NXP USA, Inc., dated October 12, 2017, as amended. |
|---|